Viewing nowCombinationDuoTelmiPlus Tablet 80/5/10mg (Telmisartan, Amlodipine, Rosuvastatin)
Telmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Korea Hutex Pharmaceutical Co., Ltd.

MFDS item code 202402997 · Approved 2024.12.18 · Insurance code 649106070
Treatment of hypertension, improvement of dyslipidemia, and suppression of atherosclerosis progression and cardiovascular risk
This medication is used for patients with essential hypertension who do not achieve blood pressure control with telmisartan and amlodipine combination therapy alone. Additionally, rosuvastatin is used as an adjunct in patients with hypercholesterolemia and hyperlipidemia when dietary and exercise modifications are insufficient. It is also beneficial for patients with primary dyslipidemia and familial hypercholesterolemia, lowering total cholesterol and LDL cholesterol levels to slow the progression of atherosclerosis. In high-risk patients with cardiovascular disease, it effectively reduces the risk of stroke, myocardial infarction, and recurrence after arterial revascularization. Thus, this medication is used to improve both blood pressure and blood lipid control, supporting cardiovascular health.
Take 1 tablet once daily with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). This medicine is for adults only. The dosage should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and rosuvastatin. For patients taking a telmisartan/amlodipine combination and rosuvastatin as separate medicines, they may be switched to this medicine (a combination tablet containing the same amounts of each active ingredient) for convenience. ○ Telmisartan/amlodipine combination Before administering the telmisartan/amlodipine combination, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components, switching directly to the telmisartan/amlodipine combination may be considered as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: In patients aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, regardless of meals. The initial dose is 5 mg once daily. The dose may be adjusted to a maintenance dose if a greater reduction in LDL cholesterol is needed. The maintenance dose is 10 mg once daily, which controls the condition in most patients. The maintenance dose should be adjusted appropriately at intervals of 4 weeks or longer, depending on LDL cholesterol levels, treatment goals, and patient response, and may be increased up to a maximum of 20 mg once daily. 2. Elderly patients: No dose adjustment is required. 3. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Special caution is required when administering rosuvastatin 20 mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Since systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of rosuvastatin is contraindicated in some of these patients. In a drug interaction study of the active ingredients of this medicine, telmisartan/amlodipine 80/10 mg and rosuvastatin 20 mg, the Cmax of rosuvastatin increased approximately 2.4-fold and the AUC approximately 1.3-fold in the presence of telmisartan/amlodipine. Therefore, when administering this medicine, assess the potential risks associated with the increase in rosuvastatin Cmax and monitor patients closely.
This medication can cause serious harm to the fetus and newborn if administered to pregnant women, so it must be discontinued immediately upon confirmation of pregnancy. Patients with allergies to any ingredients of this medication, those with certain hereditary diseases, and individuals with severe liver or kidney diseases should avoid taking it. Patients with certain health conditions, including hypertension, advanced age, or impaired liver function, require special caution when taking this medication, and regular monitoring is recommended. If symptoms such as muscle pain or weakness occur, consult a doctor immediately and conduct blood tests if necessary to check for muscle damage. This medication may interact with other drugs, so inform healthcare providers of any other medications being taken. Breastfeeding women are advised not to take this medication; if unavoidable, breastfeeding should be discontinued. This medication is not recommended for children under 18 years of age. Overdose may cause symptoms such as hypotension, dizziness, or impaired kidney function, necessitating an immediate visit to a medical facility. Keep this medication out of reach of children and do not transfer it to another container.
Viral upper respiratory infection, dyspnea, rectal bleeding, dyspepsia, atopic dermatitis, peripheral edema, chronic gastritis, various gastrointestinal disorders, hiatal hernia, infections, fungal infections, abscess, otitis media, palpitations, dependent edema, angina, rapid pulse, leg edema, abnormal ECG, insomnia, drowsiness, migraine, dizziness, paresthesia, involuntary muscle contractions, sensory loss, flatulence, constipation, gastritis, vomiting, dry mouth, hemorrhoids, gastroenteritis, enteritis, gastroesophageal reflux, toothache, nonspecific gastrointestinal disorders, gout, hypercholesterolemia, diabetes, arthritis, arthralgia, leg numbness, anxiety, depression, irritability, erectile dysfunction, low back pain, headache, fatigue, nausea, abdominal pain, drowsiness, arrhythmia, ventricular tachycardia, atrial fibrillation, bradycardia, chest pain, peripheral ischemia, syncope, orthostatic hypotension, vasculitis, peripheral neuropathy, tremors, decreased appetite, dysphagia, pancreatitis, gingival hyperplasia, allergic reactions, burning sensation, malaise, pain, stiffness, weight gain, weight loss, angioedema, polymorphic erythema, rash, erythematous rash, papular rash, diplopia, ocular pain, tinnitus, ear pain, frequent urination, urological disorders, nocturnal enuresis, dry mouth, increased sweating, hyperglycemia, thirst, leukopenia, purpura, thrombocytopenia, headache, dizziness, constipation, nausea, abdominal pain, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, angioedema, fever, leg pain, malaise, asthma, bronchitis, rhinitis, epistaxis, dermatitis, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, liver failure, amnesia, weakness, frailty, lower limb edema, thrombocytopenia, increased serum creatinine, acute renal failure, erectile dysfunction, muscle cramps, gout, arthralgia, paresthesia, chest discomfort, decreased appetite, abdominal distension, abnormal liver function tests, syncope, widespread pain
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that does not allow light in. For optimal efficacy, it should be stored at a temperature between 1°C and 30°C.
Bright pink oval film-coated tablet
30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Korea Hutex Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Il Dong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Telmisartan 80mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg +1 more
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.